-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
CG Oncology, Inc. quarterly Operating Income (Loss) history and growth rate from 2023 to 2024.
- CG Oncology, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$22.5 M, a 131% decline year-over-year.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)